Livewire Ergogenics Stock Performance
| LVVV Stock | USD 0.0007 0.0001 12.50% |
The company secures a Beta (Market Risk) of 0.92, which conveys possible diversification benefits within a given portfolio. Livewire Ergogenics returns are very sensitive to returns on the market. As the market goes up or down, Livewire Ergogenics is expected to follow. At this point, Livewire Ergogenics has a negative expected return of -0.2%. Please make sure to verify Livewire Ergogenics' maximum drawdown and rate of daily change , to decide if Livewire Ergogenics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Livewire Ergogenics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
| Total Cashflows From Investing Activities | -874.1 K | |
| Discontinued Operations | 39.4 K |
Livewire |
Livewire Ergogenics Relative Risk vs. Return Landscape
If you would invest 0.10 in Livewire Ergogenics on September 12, 2024 and sell it today you would lose (0.03) from holding Livewire Ergogenics or give up 30.0% of portfolio value over 90 days. Livewire Ergogenics is currently does not generate positive expected returns and assumes 8.7416% risk (volatility on return distribution) over the 90 days horizon. In different words, 77% of pink sheets are less volatile than Livewire, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Livewire Ergogenics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Livewire Ergogenics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Livewire Ergogenics, and traders can use it to determine the average amount a Livewire Ergogenics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0233
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LVVV |
Estimated Market Risk
| 8.74 actual daily | 77 77% of assets are less volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Livewire Ergogenics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Livewire Ergogenics by adding Livewire Ergogenics to a well-diversified portfolio.
Livewire Ergogenics Fundamentals Growth
Livewire Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Livewire Ergogenics, and Livewire Ergogenics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Livewire Pink Sheet performance.
| Return On Equity | -14.83 | |||
| Return On Asset | -0.3 | |||
| Operating Margin | (4.27) % | |||
| Current Valuation | 12.65 M | |||
| Shares Outstanding | 1.19 B | |||
| Price To Sales | 22.13 X | |||
| Revenue | 571.68 K | |||
| EBITDA | (2.26 M) | |||
| Cash And Equivalents | 164.77 K | |||
| Total Debt | 2.86 M | |||
| Debt To Equity | 4.05 % | |||
| Cash Flow From Operations | 356.16 K | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 176 K | |||
| Retained Earnings | (8.67 M) | |||
| Current Asset | 171 K | |||
| Current Liabilities | 1.09 M |
About Livewire Ergogenics Performance
Evaluating Livewire Ergogenics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Livewire Ergogenics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Livewire Ergogenics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
LiveWire Ergogenics Inc. focuses on acquiring, managing, and licensing special purpose real estate properties to produce handcrafted and organically grown cannabis products for medical and recreational adult-use in California. Livewire Ergogenics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about Livewire Ergogenics performance evaluation
Checking the ongoing alerts about Livewire Ergogenics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Livewire Ergogenics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Livewire Ergogenics generated a negative expected return over the last 90 days | |
| Livewire Ergogenics has high historical volatility and very poor performance | |
| Livewire Ergogenics has some characteristics of a very speculative penny stock | |
| Livewire Ergogenics currently holds 2.86 M in liabilities with Debt to Equity (D/E) ratio of 4.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Livewire Ergogenics has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Livewire Ergogenics until it has trouble settling it off, either with new capital or with free cash flow. So, Livewire Ergogenics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Livewire Ergogenics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Livewire to invest in growth at high rates of return. When we think about Livewire Ergogenics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 571.68 K. Net Loss for the year was (1.6 M) with profit before overhead, payroll, taxes, and interest of 540.32 K. |
- Analyzing Livewire Ergogenics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Livewire Ergogenics' stock is overvalued or undervalued compared to its peers.
- Examining Livewire Ergogenics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Livewire Ergogenics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Livewire Ergogenics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Livewire Ergogenics' pink sheet. These opinions can provide insight into Livewire Ergogenics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Livewire Pink Sheet Analysis
When running Livewire Ergogenics' price analysis, check to measure Livewire Ergogenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Livewire Ergogenics is operating at the current time. Most of Livewire Ergogenics' value examination focuses on studying past and present price action to predict the probability of Livewire Ergogenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Livewire Ergogenics' price. Additionally, you may evaluate how the addition of Livewire Ergogenics to your portfolios can decrease your overall portfolio volatility.